2013, Number 608
<< Back Next >>
Rev Med Cos Cen 2013; 70 (608)
Helicobacter pylori y cáncer gástrico
Arias LMM
Language: Spanish
References: 10
Page: 689-692
PDF size: 249.07 Kb.
ABSTRACT
Gastric adenocarcinoma
represents a health problem
worldwide due to its high
incidence and mortality rates.
It is the fourth most common
malignancy and the second
leading cause of cancer death.
Its prognosis is highly dependent
on the stage at diagnosis, usually
an advanced stage, requiring
demanding treatments and
costs. Although it is a worldwide
problem, different national
prevalence rates have led to
different options; in Japan, there
is universal screening of the
population using fluoroscopy,
followed by conventional
upper digestive endoscopy with
biopsies for the positive results,
while in most other developed
countries, the low incidence
rate makes screening not costeffective.
REFERENCES
Alpízar-Alpízar W, Une C, Sierra R. Inflammation and its Role in the Development of Gastric Carcinoma. Acta Médica Costarricense, 2009, Vol 51 (2) 76-82.
Areia M, Carvalho R, Cadime AT, Rocha Gonçalves F, Dinis-Ribeiro M. Screening for Gastric Cancer and Surveillance of Premalignant Lesions: a Systematic Review of Cost- Effectiveness Studies. Helicobacter. 2013 Apr 9.
Arguedas J. Erradicación Helicobacter Pilory. Actualización Médica Periódica, 2012, Num 136.
Arismendi-Morillo G, Hernández I, Mengual E, Abreu N, Molero N, Fuenmayor A, Romero G, Lizarzábal M. Gastric Cancer Risk Estimate in Patients with Chronic Gastritis Associated with Helicobacter Pylori Infection in a Clinical Setting. Rev Gastroenterol Mex. 2013 Mar 25. 01- 23.
Kusters JG, Van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter Pylori Infection. Clin Microbiol. Rev 2006; 19: 449–90.
Li TT, Qiu F, Wang ZQ, Sun L, Wan J. Rare Case of Helicobacter Pylori -Related Gastric Ulcer: Malignancy or Pseudomorphism? .World J Gastroenterol 2013 Mar 28;19(12).
Luther J, Higgins PD, Schoenfeld PS, et al. Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter Pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability. Am J Gastroenterol 2010;105:65-73.
Sasagawa T, Solano H, Mena F. Gastric Cancer in Costa Rica. Gastrointestinal Endoscopy, 1999; 50:4.
Sierra R. Cáncer Gástrico, Epidemiología y Prevención. Acta Médica Costarricense, 2002,v.44, n.2.
Suerbaum S, Michetti P. Helicobacter Pylori Infection. N Engl J Med 2002; 347: 1175–86.